Evidence map›Paper›PMID 39992383›Full record

ReviewZeitschrift fur Gerontologie und Geriatrie2025

Inhalation treatment of chronic obstructive pulmonary disease (COPD) in older patients.

Carla Stenmanns, Helmut Frohnhofen, Claudia Münks-Lederer, Sandhya Matthes

Abstract readReview
PubMed Publisher
In one paragraph

Review in Zeitschrift fur Gerontologie und Geriatrie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carla StenmannsDepartment of Orthopedics and Trauma Surgery, Heinrich-Heine-University, Moorenstraße 5, 40225, Duesseldorf, Germany. Carla.stenmanns@med.uni-duesseldorf.de.
Helmut FrohnhofenDepartment of Orthopedics and Trauma Surgery, Heinrich-Heine-University, Moorenstraße 5, 40225, Duesseldorf, Germany.
Claudia Münks-LedererDepartment of Pneumology, Klinikum Leverkusen, Leverkusen, Germany.
Sandhya MatthesBethanien Hospital, Institute for Pneumology at the University of Cologne, Solingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is frequent in older patients. Frailty, cognitive impairment and sarcopenia are predictors for inadequately performed lung function testing as well as presenting challenges in subsequent disease management. Underdiagnosis and suboptimal treatment are often the result of incomplete assessment of older COPD patients. Problems associated with older COPD patients are not adequately addressed in international guidelines, although numerous evidence-based strategies are available. A key aspect is the management of the various inhaler devices. Up to 60-80% of older patients with COPD do not use the inhalers correctly. Even when the inhaler technique is correct, there is undertreatment if the required inspiratory flow cannot be achieved. Given the high rate of suboptimal inhaler treatment in older patients with COPD, an analysis of the pitfalls is important. An objective measurement of inspiratory flow and assessment of cognition and coordination are essential. A possible clinical algorithm for the assessment of older patients with respect to inhaler treatment of COPD is presented in a consensus approach by the Pneumological Geriatric Medicine Working Group of the German Society of Pulmonologists.

Indexed as

Bronchodilator AgentsNebulizers and VaporizersPulmonary Disease, Chronic ObstructiveAdministration, InhalationAgedAged, 80 and overFemaleGeriatric AssessmentHumansMaleBronchodilator AgentsChronic obstructive pulmonary disease (COPD)Cognitive impairmentFrailtyGeriatric assessmentPeak inspiratory flow rateSarcopenia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.